12:06 EDT = Pharming (PHAR) Group NV ADS trading resumes
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAR:
- = Pharming Group NV ADS trading halted, volatility trading pause
- Pharming price target raised to EUR 2.45 from EUR 2 at RBC Capital
- Pharming price target raised to $41 from $40 at Oppenheimer
- Pharming Group’s Strong Financial Performance and Strategic Developments Justify Buy Rating
- Pharming Group Reports Strong Q2 2025 Revenue Growth